Research Area:
Endocrine & Peptide Research

Product Description:
CJC-1295 (No DAC) + Ipamorelin is a synthetic peptide research blend supplied in lyophilized powder form for use in qualified laboratory environments. The material is intended exclusively for in vitro and analytical research involving peptide characterization, receptor-interaction studies, endocrine signaling pathways, and controlled assay-based experimental systems.

CJC-1295 (No DAC) is a GHRH-related peptide analog, while Ipamorelin is a synthetic peptide studied in relation to growth hormone secretagogue receptor (GHS-R1a) signaling. The combination is used as a research model for investigating distinct signaling inputs within the growth hormone regulatory axis.

Product Designation Note:
This product is identified as CJC-1295 + Ipamorelin (No DAC) for research cataloging and laboratory reference purposes. The formulation contains 5 mg CJC-1295 (No DAC) and 5 mg Ipamorelin per vial. It is supplied exclusively as a research material and is not represented as a pharmaceutical product.

Research Applications:
In controlled laboratory research settings, this peptide blend may support investigation of:

• GHRH receptor-related peptide interactions
• GHS-R1a receptor binding and signaling characteristics
• Comparative analysis of distinct endocrine signaling pathways
• Peptide structure, integrity, stability, and degradation
• Receptor-interaction and assay development studies
• Analytical characterization and quality-control workflows
• In vitro investigation of pathways associated with growth hormone regulation

All research activities are conducted exclusively in non-human, non-clinical experimental models.

Storage and Handling:
Store the lyophilized material according to validated laboratory storage conditions and supplier specifications.

Protect from light, moisture, and unsuitable environmental conditions that may affect peptide integrity.

After preparation for analytical testing, handle and store the material according to validated laboratory protocols appropriate to the specific assay.

Maintain appropriate aseptic laboratory handling practices where required.

Product Specifications:
CJC-1295 (No DAC): 5 mg
Ipamorelin: 5 mg
Purity: ≥99% (HPLC Certified)
Form: Synthetic peptide blend
Appearance: Lyophilized white powder
Application: In vitro and analytical research only
Packaging: Sealed laboratory vial

Compliance Notice:
This material is FOR RESEARCH USE ONLY and is supplied as an analytical research material. CJC-1295 (No DAC) and Ipamorelin are investigated in laboratory research involving endocrine signaling and growth hormone-related pathways.

The specific combination of CJC-1295 (No DAC) and Ipamorelin has limited direct clinical evidence, and research findings involving individual components or related compounds should not be interpreted as evidence of clinical efficacy for the combination.

This research material is not intended for human or veterinary use, is not supplied as a pharmaceutical drug product, and has not been approved for clinical administration. No dosage, administration, therapeutic, or performance-related claims are made.

By purchasing this product, the buyer represents and warrants that the material will be used exclusively for legitimate in vitro, analytical, and non-clinical research purposes by appropriately qualified personnel.